Malignant neoplasia arising from ovarian remnants following bilateral salpingo‑oophorectomy (Review)

Imai,Atsushi; Matsunami,Kazutoshi; Takagi,Hiroshi; Ichigo,Satoshi

doi:10.3892/ol.2014.2089

Malignant neoplasia arising from ovarian remnants following bilateral salpingo‑oophorectomy (Review)

Authors:
- Atsushi Imai
- Kazutoshi Matsunami
- Hiroshi Takagi
- Satoshi Ichigo
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Matsunami General Hospital, Gifu 501‑6062, Japan
Published online on: April 25, 2014 https://doi.org/10.3892/ol.2014.2089
Pages: 3-6

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ovarian remnant syndrome (ORS) is a rare, but well‑known gynecological complication, most often induced by difficult bilateral salpingo‑oophorectomy (BSO) procedures that leave residual ovarian tissue on the pelvic wall. The most common preexisting conditions for this complication include endometriosis, pelvic inflammatory disease and prior abdominal surgery. The residual ovarian tissue may eventually cause malignant development. A total of 12 cases of malignant and benign tumors (clear cell adenocarcinoma in 1 case, mucinous‑type tumors in 2, endometrioid‑type tumors in 5, adenocarcinoma in 3 and border serous neoplasia in 1) and 21 benign cysts developing from an ovarian remnant have been described in the literature to date. Endometriosis, known to increase the risk of ovarian cancer, predisposes patients to ORS, with an incidence rate of 30 to 50% in ORS patients with ovarian carcinoma. Although the true incidence of ORS remains unknown, when endometriotic adhesions are diagnosed during BSO, the possibility of ORS and subsequent ovarian malignant transformation may mandate complete surgical resection.

View Figures

View References

1	Magtibay P and Magrina J: Ovarian remnant syndrome. Clin Obstet Gynecol. 49:526–534. 2006.
2	Magtibay PM, Nyholm JL, Hernandez JL and Podratz KC: Ovarian remnant syndrome. Am J Obstet Gynecol. 193:2062–2066. 2005.
3	Shemwell RE and Weed JC: Ovarian remnant syndrome. Obstet Gynecol. 36:299–303. 1970.
4	Kho RM and Abrao MS: Ovarian remnant syndrome: etiology, diagnosis, treatment and impact of endometriosis. Curr Opin Obstet Gynecol. 24:210–214. 2012.
5	Fukunaga M, Nomura K, Ishikawa E and Ushigome S: Ovarian atypical endometriosis: Its close association with malignant epithelial tumours. Histopathology. 30:249–255. 1997.
6	Kho RM, Magrina JF and Magtibay PM: Pathologic findings and outcomes of a minimally invasive approach to ovarian remnant syndrome. Fertil Steril. 87:1005–1009. 2007.
7	Minke T, DePond W, Winkelmann T and Blythe J: Ovarian remnant syndrome: study in laboratory rats. Am J Obstet Gynecol. 171:1440–1444. 1994.
8	Na KY, Sung JY, Won KY, Kim GY, Lim SJ and Lee SH: Ovarian remnant syndrome at the trochar site: a report of a rare complication following laparoscopic ovarian surgery. Korean J Pathol. 47:304–306. 2013.
9	Zapardiel I, Zanagnolo V, Kho RM, Magrina JF and Magtibay PM: Ovarian remnant syndrome: Comparison of laparotomy, laparoscopy and robotic surgery. Acta Obstet Gynecol Scand. 91:965–969. 2012.
10	Arden D and Lee T: Laparoscopic excision of ovarian remnants: retrospective cohort study with long-term follow-up. J Minim Invasive Gynecol. 18:194–199. 2011.
11	Chao HA: Ovarian remnant syndrome at the port site. J Minim Invasive Gynecol. 15:505–507. 2008.
12	Kamprath S, Possover M and Schneider A: Description of a laparoscopic technique for treating patients with ovarian remnant syndrome. Fertil Steril. 68:663–667. 1997.
13	Nezhat C, Kearney S, Malik S, Nezhat C and Nezhat F: Laparoscopic management of ovarian remnant. Fertil Steril. 83:973–978. 2005.
14	Donnez O, Squifflet J, Marbaix E, Jadoul P and Donnez J: Primary ovarian adenocarcinoma developing in ovarian remnant tissue ten years after laparoscopic hysterectomy and bilateral salpingo-oophorectomy for endometriosis. J Minim Invasive Gynecol. 14:752–757. 2007.
15	Mahdavi A, Kumtepe Y and Nezhat F: Laparoscopic management of benign serous neoplasia arising from persistent ovarian remnant. J Minim Invasive Gynecol. 14:654–656. 2007.
16	Narayansingh G, Cumming G, Parkin D and Miller I: Ovarian cancer developing in the ovarian remnant syndrome. A case report and review of the literature. Aust NZ J Obstet Gynaecol. 40:221–223. 2000.
17	Melin A, Lundholm C, Malki N, Swahn M, Sparen P and Bergqvist A: Endometriosis as a prognostic factor for cancer survival. Int J Cancer. 129:948–955. 2011.
18	Oral E, Ilvan S, Tustas E, Korbeyli B, Bese T, Demirkiran F, Arvas M and Kosebay D: Prevalence of endometriosis in malignant epithelial ovary tumours. Eur J Obstet Gynecol Reprod Biol. 109:97–101. 2003.
19	Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA and Weiss NS: Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery. Cancer Causes Control. 19:1357–1364. 2008.
20	Worley MJ, Welch WR, Berkowitz RS and Ng SW: Endometriosis-associated ovarian cancer: a review of pathogenesis. Int J Mol Sci. 14:5367–5379. 2013.
21	Kobayashi H, Sumimoto K, Moniwa N, Imai M, Takakura K, Kuromaki T, Morioka E, Arisawa K and Terao T: Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in shizuoka, Japan. Int J Gynecol Cancer. 17:37–43. 2007.
22	Brinton LA, Sakoda LC, Sherman ME, Frederiksen K, Kjaer SK, Graubard BI, Olsen JH and Mellemkjaer L: Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomark Prev. 14:2929–2935. 2005.
23	Puls LE, Powell DE, DePriest PD, Gallion HH, Hunter JE, Kryscio RJ and van Nagell JR Jr: Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma. Gynecol Oncol. 47:53–57. 1992.
24	Johns DA and Diamond MP: Adequacy of laparoscopic oophorectomy. J Am Assoc Gynecol Laparosc. 1:20–23. 1993.
25	Ichigo S, Takagi H, Matsunami K, Murase T, Ikeda T and Imai A: Clear cell carcinoma developing in remnant ovary after hysterectomy and bilateral salpingo-oophorectomy for endometriosis. J Gynecol Surg. (In Press).
26	Fueyo J, Garcés JM, Soriano JC, Coll J and Rubiés-Prat J: Adenocarcinoma of the ovary in the ovarian remnant. Rev Clin Esp. 186:415–416. 1990.(In Spanish).
27	Brühwiler J and Lüscher K: Ovarian cancer in the ovarian remnant syndrome. Geburtshilfe Frauenheilkd. 51:70–71. 1991.(In German).
28	Glaser D, Bürrig KF and Mast H: Ovarian cancer in ovarian remnant syndrome? Geburtshilfe Frauenheilkd. 52:436–437. 1992.(In German).
29	Elkins TE, Stocker RJ, Key D, McGuire EJ and Roberts JA: Surgery from ovarian remnant syndrome. Lessons learned from difficult cases. J Reprod Med. 39:446–448. 1994.
30	Dereska NH, Cornella J, Hibner M and Magrina JF: Mucinous adenocarcinoma in an ovarian remnant. Int J Gynecol Cancer. 14:683–686. 2004.
31	Kazadi Buanga J, Laparte Escorza MC and Lopez Garcia G: Ovarian remnant syndrome. A case report of a malignancy. J Gynecol Obstet Biol Reprod (Paris). 21:769–772. 1992.
32	Scott RT, Beatse SN, Illions EH and Snyder RR: Use of the GnRH agonist stimulation test in the diagnosis of ovarian remnant syndrome. A report of three cases. J Reprod Med. 40:143–146. 1995.
33	Koch MO, Coussens D and Burnett L: The ovarian remnant syndrome and ureteral obstruction: medical management. J Urol. 152:158–160. 1994.
34	Fat BC, Terzibachian JJ, Bertrand V, Leung F, de Lapparent T, Grisey A, Maillet R and Riethmuller D: Ovarian remnant syndrome: diagnostic difficulties and management. Gynecol Obstet Fertil. 37:488–494. 2009.(In French).